Exane Derivatives Gsk PLC Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding GSK
# of Institutions
20Shares Held
176KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.43 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.11 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$661,3690.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL18.6KShares$615,8040.0% of portfolio
-
Loveless Wealth Management LLC15KShares$496,6800.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $67.3B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...